# The Use of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle to Treat Sleep Bruxism

> **NCT05620316** · NA · COMPLETED · sponsor: **Damascus University** · enrollment: 22 (actual)

## Conditions studied

- Nocturnal Bruxism

## Interventions

- **DRUG:** BOTOX® Injection
- **OTHER:** Prick skin

## Key facts

- **NCT ID:** NCT05620316
- **Lead sponsor:** Damascus University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2021-09-15
- **Final completion:** 2022-02-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2022-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05620316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05620316, "The Use of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle to Treat Sleep Bruxism". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05620316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*